Portrait of Eveline Oestreicher Stock
ucsf logo

Eveline Oestreicher Stock, MD

She | Her | HersPreventive Cardiology • Cardiology
Cardiology Mission Bay – Mission Bay Blvd. South
415-353-2873
Portrait of Eveline Oestreicher Stock
Portrait of Eveline Oestreicher Stock
ucsf logo

Eveline Oestreicher Stock, MD

She | Her | HersPreventive Cardiology • Cardiology
Cardiology Mission Bay – Mission Bay Blvd. South
415-353-2873

On this page

About me

Dr. Eveline Oestreicher Stock is a cardiologist who cares for patients who have heart disease or are at risk of developing it. She has particular interests in preventive and noninvasive cardiology, lipidology (the study of fats in the blood), and genetic underpinnings of endocrine factors related to cardiovascular risk in hypertension and diabetes. She takes a personalized approach to treatment to ensure the best possible health outcomes; this includes taking a deep dive in the evaluation of her patients' cardiovascular risks, and counseling them on beneficial lifestyle changes.

Her research focuses on the mechanisms involved in the development and progression of atherosclerosis (the accumulation of fat on artery walls), prevention of atherosclerosis, heart disease and stroke.

She earned her medical degree from Pontificia Universidad Católica de Chile, where she also completed a residency in internal medicine, serving as chief resident, and a fellowship in endocrinology and metabolism. She later completed a residency in internal medicine at Massachusetts General Hospital and a fellowship in endocrine hypertension at Brigham and Women's Hospital. She continued her training at UCSF, completing fellowships in cardiology and preventive cardiology.

She serves as co-chair of the Right Care Initiative of Bay Area Silicon Valley University of Best Practices, a collaborative plan to implement scientifically proven strategies for eliminating preventable heart attacks and strokes.

Education & training

Fellowship

  • Cardiovascular Disease, University of CA at San Francisco School of Med
  • Endocrinology and Metabolism, Pontificia Universidad Catolica de Chile

Residency

  • Internal Medicine, Massachusetts General Hospital GME

Internship

  • Internal Medicine, Massachusetts General Hospital GME

Degree

  • MD, Pontificia Universidade Catolica de Sao Paulo

Academic title

  • Health Sciences Clinical Professor

My expertise

Locations

    Reviews

    Average rating

    5
    5 out of 5 Stars
    76 ratings
    About provider reviews

    Showing 1-6 of 34 reviews

    Sort by
    • 5 out of 5 Stars
      June 21, 2026

      Dr Stock is a very friendly, efficient, and competent provider - she makes what UCSF Health is

    • 5 out of 5 Stars
      June 20, 2026

      Dr. Stock is very knowledgeable, professional and she istens to me. She also cares. She is highly recommended.

    • 5 out of 5 Stars
      June 17, 2026

      Dr Stock is extremely knowledgeable and is also very kind and caring. I am so happy to receive care from her.

    • 5 out of 5 Stars
      June 13, 2026

      Dr Stock is absolutely amazing great in every category, brilliant caring and unusually adaptive to the patient

    • 5 out of 5 Stars
      June 6, 2026

      The entire experience was just outstanding and very reassuring. Extraordinary expertise combined with patient informative conversation about very concerning topics. I could not have been in better hands.

    • 5 out of 5 Stars
      June 4, 2026

      Dr. Stock is an amazing provider. She is up-to-the-minute knowledgeable about treatment and care protocols and she is empathetic.

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.

    The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.